Table 3.

Validation of the multivariate analysis for evaluating the risk of intubation/mortality at 28 days by Bootstrapping method using 1000 random samples.

		B	95% CI	p
Intubated/Death COVID-19 disease	LPO >1948.17 μM	0.94	0.16–1.96	0.015
	Obesity	0.18	−0.91 – 1.72	0.729
	Diabetes mellitus	1.04	−0.20 – 2.13	0.026
	Chronic hepatic disease	2.01	0.97–3.71	0.005
	Septic Shock	0.96	0.14–2.39	0.046
	Lymphocytes <875 cells/mm3	−1.50	(-2.71) – (−0.64)	0.002
	Neutrophils >5480 cells/mm3	0.83	0.13–1.79	0.026